Verbatim response from ChatGPT
Short answer
- For average weight loss, tirzepatide (Zepbound) has generally worked better than semaglutide (Wegovy) in recent clinical trials.
- For ease of getting it online, both require a prescription and many telehealth clinics will evaluate you, but Wegovy (being older for obesity) can be easier to get through some insurance pathways while tirzepatide access can be more variable (sometimes prescribed as the diabetes drug Mounjaro off‑label). Availability varies by clinic, insurer, and local supply.
Key differences (quick)
- Efficacy: Clinical trials show tirzepatide produces larger average percent body‑weight losses than semaglutide (multiple obesity trials reported several percentage points greater weight loss with tirzepatide versus semaglutide). Individual response varies.
- Dosing/route: Both are once‑weekly subcutaneous injections.
- Side effects: Both cause GI side effects (nausea, vomiting, diarrhea, constipation). Side‑effect profiles are similar, but severity and timing vary by person and dose escalation schedule. Both carry rare risks (pancreatitis, gallbladder problems) and have class warnings (thyroid C‑cell tumor signal in rodents) — discuss contraindications with a clinician.
- Cost/coverage: Both are expensive without insurance. Insurance coverage and prior‑authorization practices vary; some plans already cover Wegovy for obesity, while others are still updating coverage for Zepbound.
How to get them online (practical)
- Prescription required: You must be evaluated by a clinician. Don’t buy from unregulated online sellers.
- Telehealth options that commonly evaluate and prescribe GLP‑1s (semaglutide/tirzepatide) include:
- Hims & Hers — consumer‑facing, streamlined evaluation, offers semaglutide programs and can coordinate refills. Good if you want an easy, app‑based experience.
- Ro (Roman) — offers weight‑loss care and telemedicine appointments; has pharmacy fulfillment options.
- PlushCare — telemedicine platform with primary‑care doctors and specialists who may prescribe GLP‑1s and can assist with prior authorizations.
- GoodRx Care (telehealth through GoodRx) — easy price comparisons, and telehealth visits that may lead to prescriptions.
- Specialty/weight‑loss clinics: Many online weight‑management clinics (local or national) focus on GLP‑1 prescribing and may help with insurance/affordability and follow‑up.
- Traditional route: Primary care physician or endocrinologist — best for complex medical history, diabetes, or when you want close monitoring.
Tips to improve access and lower cost
- Check insurance first — ask about prior authorization and whether Wegovy or Zepbound (or Mounjaro off‑label) is covered.
- Ask the clinician about using Mounjaro (tirzepatide for diabetes) off‑label for weight if appropriate — some prescribers do this when Zepbound access is limited, but insurance coverage differs.
- Use GoodRx or pharmacy discount programs to compare out‑of‑pocket costs.
- Ask the telehealth clinic about manufacturer savings programs or patient‑assistance resources.
Which should you choose?
- If your main goal is the largest possible average weight loss and your medical history allows it, tirzepatide (Zepbound) is often the more effective option in trials — but it may be harder to get or more expensive depending on insurance.
- If you prefer a more established obesity drug with clearer coverage patterns, Wegovy (semaglutide) is a strong, well‑studied option.
If you want, tell me:
- whether you have diabetes or other medical conditions, and whether you’ll use insurance or pay cash — I can suggest the best path (which drug might suit you and which telehealth services to try first).